Please add info@sitcancer.org to your safe senders list.
March 2015 - In this Issue
Society Updates | SITC Resources | Get Involved
A Message from the President
Dear Colleagues,
As the world’s leading member-driven organization dedicated to professionals working in cancer immunotherapy, SITC has continually delivered the latest, cutting-edge information to all stakeholders—scientists, clinicians, researchers, industry, government, patients and advocates alike. The dissemination of information is more important than ever given the major advances in the field over the last few years.
In response to the unprecedented needs in the field, and in celebration of our 30th year of advancing cancer immunotherapy worldwide, SITC has extended our Annual Meeting & Associated Programs to provide more opportunities for scientific exchange, education and networking than ever before.
Please plan to join us in National Harbor, Maryland from November 4 – 8, 2015 as leaders from around the world come together to discuss and debate the most important developments in the cancer immunotherapy field. In this momentous year, SITC will celebrate the history of tumor immunology and immunotherapy—with several surprises for meeting attendees—as well as articulate the contemporary issues in tumor immunotherapy as we work together to craft the vision of immunotherapy for the future.
Prof. Tasuku Honjo, 2015 Richard V. Smalley, MD Memorial Award recipient, will be delivering the keynote address, and we will be featuring a special session on Milestones in Immunotherapy with talks from Dr. James P. Allison, Dr. Cornelis J.M. Melief, Dr. Steven A. Rosenberg and Dr. Robert Schreiber. These are among the sessions you don’t want to miss!
I look forward to seeing you in person and continuing our work in this historic time.
Best regards,
Howard L. Kaufman, MD, FACS
SITC President
P.S. More information is available on our SITC 2015 microsite. Stay tuned for registration and abstract submission announcements coming soon!
Society Updates
SITC 2015 Microsite Now Available!
.jpg)
Access the latest information, including program schedules and faculty listings via the links below!
| 30th Anniversary Annual Meeting General Information | Schedule |
International Symposium on Cancer Immunotherapy: Featuring Today’s Innovators, Tomorrow’s Leaders Presented by the World Immunotherapy Council General Information |
| Workshop: New Perspectives on Target Antigens in the Changing Cancer Immunotherapy Landscape General Information | Schedule |
Early Career Scientist Activities General Information |
| Primer on Tumor Immunology and Cancer ImmunotherapyTM General Information | Schedule |
Biomarkers Debate General Information |
| Global Regulatory Summit Featuring regulatory agency representatives from around the world General Information |
Cancer Immunotherapy Patient Forum Presented by SITC, Global Resource for Advancing Cancer Education & Melanoma Research Alliance General Information |
SITC Resources
Available Clinical Trials for Combatting Colorectal Cancer
March is Colorectal Cancer Awareness Month. Among cancers that affect both men and women, colorectal cancer is the second leading cause of cancer deaths in the United States. Every year, about 140,000 Americans are diagnosed with colorectal cancer, and more than 50,000 people die from it.
Learn about available immunotherapy-based clinical trials for colorectal cancer in SITC's Understanding Cancer Immunotherapy Patient Resource Guide, and share it with your patients and colleagues.
To request hard copies, contact info@sitcancer.org.
Get Involved
Spread the Word about Advances in Cancer ImmunotherapyTM
SITC President Howard L. Kaufman, MD, FACS and SITC Board Director Jedd D. Wolchok, MD, PhD are organizing Advances in Cancer ImmunotherapyTM for Saturday, March 28 in Princeton, New Jersey!
This introductory, CME-certified program will provide oncologists and the entire team involved in treating cancer patients with an understanding of basic immunology principles in the clinical application and management of cancer immunotherapy and discuss emerging drugs and concepts in the cancer immunotherapy field. Interested parties can get more information and register here.
In addition, SITC has 10 regional CME- and CNE-certified Advances in Cancer ImmunotherapyTM programs scheduled for the remainder of this year! Get more information, including dates, locations and full accreditation information, here.
Join SITC Leaders for the 2nd Immunotherapy of Cancer Conference (ITOC-2) in Munich, Germany | March 25 – 27, 2015
SITC is proud to partner with The Cancer Drug Development Forum (CDDF) on ITOC-2, a European meeting intended to provide a forum for discussion of early clinical drug development and address its unique challenges by preclinical and clinical researchers in the field of immunotherapy.
Representatives from academia, industry and other stakeholders who are involved in the development of novel anticancer agents are encouraged to attend this timely event. Learn more, including how to register, here.
View All Upcoming SITC Collaborative Meetings
Submit Your Manuscript to JITC & Qualify for the JITC Best Paper Awards
The Journal for ImmunoTherapy of Cancer (JITC), SITC's own open access, peer-reviewed journal, is a targeted outlet for the publication of original research articles, literature reviews, position papers and discussion on all aspects of tumor immunology and cancer immunotherapy—from basic research to clinical application.
SITC will once again be offering two $1,000 USD awards for the best papers submitted in the Clinical/Translational and Basic Science categories. To be eligible, papers must be published in JITC by August 18, 2015. In addition, SITC members are encouraged to take advantage of waived article processing charges for manuscripts accepted in 2015—a $2,500 value!
Submit your manuscript here.
Latest Career Opportunities from SITC's Job Board
Professor/Reader in Cancer Immunology and Immunotherapy
Nottingham Trent University – United Kingdom
Research Scientist I, Immunology
Gilead Sciences – Foster City, CA
If you are interested in posting an open position to SITC's Job Board, please reference this agreement form for posting criteria or contact SITC at info@sitcancer.org.
Society for Immunotherapy of Cancer (SITC)
555 East Wells Street, Suite 1100 | Milwaukee, Wisconsin 53202-3823 USA
Phone: +1 414 271 2456 | Email: info@sitcancer.org
© 2015 Society for Immunotherapy of Cancer
Join us on:
You have received this message because you have had previous contact with the Society for Immunotherapy of Cancer. If you do not wish to be included in our mailing list, please forward this message to info@sitcancer.org with the word "Remove" in the subject line.
Please add info@sitcancer.org to your safe senders list.